Kontinuierliche subkutane Buprenorphinapplikation in der Therapie karzinombedingter Schmerzen

@article{Gralow2006KontinuierlicheSB,
  title={Kontinuierliche subkutane Buprenorphinapplikation in der Therapie karzinombedingter Schmerzen},
  author={Ingrid Gralow and W. Frhr von Hornstein and Eberhard Schleyer and Wolfgang Hiddemann},
  journal={Der Schmerz},
  year={2006},
  volume={9},
  pages={117-123}
}
Introduction Buprenorphine is well known in cancer pain therapy because of the long duration of its action and high analgesic potency. Many studies exist about the intravenous and sublingual application form; however, few data are available on its use by the continuous subcutaneous route. Methods Twenty-five patients were analysed retrospectively over 956 days who has been treated with continuous subcutaneous buprenorphine for cancer-related pain. In 7 of these 25 patients plasma analyses were… CONTINUE READING